Volt Information Sciences Inc (VOLT) Quote

https://x.com/sirmojojon/status/1833458755771437129?s=46&t=v0R0GCgSTgyRIympOF0PVw

http://archive.fast-edgar.com/20240909/AV29D62CLZ22OZ3V22ZS2ZY2CMQJZ222Z266/ea021301401ex99-1_immuron.htm

Never seen this board so active before, what’s up with that !

Gold mining deals continue to get done. This is obviously in anticipation of a higher gold price moving forward.

https://www.marketwatch.com/story/anglogold-ashanti-strikes-2-5-billion-deal-to-buy-egyptian-gold-miner-centamin-adc224ea?mod=home-page

$CBDW The AI Platform: A Game Changer in Biotechnology

#Adnexus Biotech's AI platform is a cornerstone of its innovation strategy. This advanced technology is designed to streamline and enhance the drug discovery and development process. https://allcapresearch.com/f/the-ai-platform-

Sources? Read the news. What are your sources that the West’s focus on the importance of securing critical minerals and supply chains has waned? If anything, China’s new export controls on antimony has ratcheted up the need. Nothing from the gov’t has been ruled out to my knowledge, so it’s all pot

you can tell that story to a 3 year old kid or somebody who just joined IHUB...not me pal...enjoy

ruskie1---- can you change the past? I can't. Yes before we were told GSS I believe was their name would be able to handle 8 tons the first year and up to 40 tons later.
That goes back to my thoughts of years ago. Not enough hands on supervision to see this through. That was then and this i

See you tomorrow 💕

The beta versus the full service platform will continue to be adjusted. The full platform is currently generating revenues over 500k annual. I said early that I believed the professional service would get the lions share of the revenues, and has yet to include a casino partnership or partnerships. T

Updated

Cash $209147

KINS 10000 shares

Nice

DUMPED all my $1zzz at $1.75

Yes

I don't really care what some random twitter says. I have my own set of questions and since we're going to be here forever, I'm in no rush to get it all wrapped up quickly. See what guys tomorrow!

Plug Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
September 09 2024 - 7:00AM
https://ih.advfn.com/stock-market/NASDAQ/plug-power-PLUG/stock-news/94513612/plug-announces-participation-at-the-h-c-wainwrigh

Plug Power Inc. (NASDAQ:

They certainly don't stray from their narrow uninspiring path, at least from an investor standpoint. Again and again nothing of substance. They did mention Ask Veri though. Wonder how they are paying for their presence at IBC. Maybe employees have to pay out of pocket.

Sell SQQQ @ $9.40

Sell 22000 SQQQ @ $9.40 = $206800

So what happened to serial liar MK's forth forecast since 2021 for an IDE submission within 45 days of his withdrawing the last IDE submission? Obviously there are serious issues FDA has flagged. The earlier tells were his doing more rabbit tests in 2023 after lying that the testing had concluded,

$AGBA Possible $GME level squeeze in store for $AGBA https://youtube.com/watch?v=4eI9Ej5X7Gs…
@AGBAgroup

Irrelevant. That’s from 4 years ago.

I really miss being able to buy expert market before they go back to current status

Trending - $CBDW The AI Platform: A Game Changer in Biotechnology

#Adnexus Biotech's AI platform is a cornerstone of its innovation strategy. This advanced technology is designed to streamline and enhance the drug discovery and development process. https://allcapresearch.com/f/the-a

JustKate can you read the English language?
LAS VEGAS, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) ("AABB" or the "Company") is pleased to announce that the Company is expecting to receive an expanded certified geological technical report by the first week of September

Carisma Therapeutics and Moderna expand collaboration to develop CAR-M therapies
Carisma Therapeutics (CARM) is expanding its in vivo chimeric antigen receptor macrophage and monocyte - together, CAR-M - collaboration with Moderna (MRNA) to include the nomination of two targets for the treatm